Abstract:Four new copper(II) complexes were synthesized and characterized with the general formula [Cu(N-N)(Th)(NO3)], where N-N corresponds to the N-heterocyclic ligands 1,10-phenanthroline (phen), 2,2'-bipyridine (bipy), 4,7-diphenyl-1,10-phenanthroline (dpp) and 4,4-dimethyl-2,2'-bipyridine (dmbp) and Th represents the N,N-dibenzyl-N'-benzoylthiourea. The cytotoxic activities of the complexes against HCT116 (human colon carcinoma), HepG2 (human hepatocellular carcinoma), and non-tumor MRC-5 (human lung fibroblast) cells were investigated. The copper(II) complexes 1-4 were characterized by spectroscopic techniques, as well as the complexes 1 and 2 were studied by single-crystal X-ray diffraction. The complexes present a five-coordinated structure with one nitrate ligand as monodentate at axial position and two bidentate ligands, N-heterocyclic and N,N-dibenzyl-N'-benzoylthiourea. The complexes showed promising IC50 values, ranging from 0.3 to 9.0 μM. Furthermore, interaction studies with biomolecules such as DNA and Bovine Serum Albumin (BSA), which can act as possible biological targets of the complexes, were carried out. The studies suggest that the compounds interact moderately with DNA and BSA. Complexes 1, 2, and 4 did not lead to cell accumulation at any stage of the cell cycle, but cause a significant increase in internucleosomal DNA fragmentation. On the other hand, compound 3 caused cell cycle arrest in S phase, while doxorubicin caused cell cycle arrest in G2/M phase. The effect of structural modifications on the metal compounds was correlated with their biological properties and it was concluded that an increase in biological activity occurred with increasing extension of the diimine ligands. Thus, the complex 3 was the most promising one.

Exploring the BSA-, DNA-binding, cytotoxicity and cell cycle evaluation of ternary copper(II)/diimine complexes with N,N-dibenzyl-N'-benzoylthiourea as promising metallodrug candidates